https://www.selleckchem.com/pr....oducts/isoxazole-9-i
e intervention to improve risk-of-falling outcomes in community-dwelling older adults. In a future trial, alternative clinical tools should be considered to minimize the presence of ceiling/floor effects. A future large trial is needed to confirm sideways walking as a fall prevention intervention. ClinicalTrials.gov identifier NCT04505527 . Retrospectively registered 10 August 2020. ClinicalTrials.gov identifier NCT04505527 . Retrospectively registered 10 August 2020. Osteopontin plays critical roles in osteoarthritis (OA) by
Beğen
Yorum Yap
Paylaş
